Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Q Campbell-Hewson

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
ESMO Open|February 5, 2025
Efficacy, safety, and pharmacokinetics of eribulin as monotherapy or in combination with irinotecan for patients with pediatric rhabdomyosarcoma, non-rhabdomyosarcoma soft tissue sarcoma, or Ewing sarcomaM Casanova, C M Albert, F Bautista, et al.
ESMO Open|September 25, 2021
Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)<sup>☆</sup>N Gaspar, Q Campbell-Hewson, S Gallego Melcon, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
ESMO Open|February 5, 2025
Efficacy, safety, and pharmacokinetics of eribulin as monotherapy or in combination with irinotecan for patients with pediatric rhabdomyosarcoma, non-rhabdomyosarcoma soft tissue sarcoma, or Ewing sarcomaM Casanova, C M Albert, F Bautista, et al.
ESMO Open|September 25, 2021
Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)<sup>☆</sup>N Gaspar, Q Campbell-Hewson, S Gallego Melcon, et al.
Pageof 1